INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2010
|
Total net assets |
£99.6m |
|
NAV per share |
166.1p |
|
Share price |
139.0p |
|
Total value of unquoted investments |
£22.7m |
|
Total number of portfolio companies |
60 |
|
Cash |
(3)% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
6.40 |
|
Micromet |
5.87 |
|
Amgen |
5.59 |
|
Gilhead Sciences |
5.11 |
|
Shire Ltd |
5.04 |
|
Alexion Pharmaceuticals |
3.90 |
|
Insulet |
3.66 |
|
Teva |
3.38 |
|
Genzyme |
3.33 |
|
Cadent |
3.16 |
|
|
----------- |
|
Total |
45.44 |
|
Geographical Allocation |
% |
|
United States |
78 |
|
Europe |
23 |
|
Australia |
2 |
|
Cash |
(3) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
80 |
|
Unquoted |
23 |
|
Cash |
(3) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 NOVEMBER 2010